Table 3. CR and Survival Outcome... | American Society of Hematology

Table 3.

CR and Survival Outcome According to Prognostic Factors

Factor	No. of Patients	CR Rate (%)	5-Year Overall Survival (%)
Age (yr)
60-69	189	61	53
70-79	94	59	51
≥80	67	56	47
Sex
Male	174	57	48
Female	176	59	50
B symptoms
Absent	238	60	50
Present	112	57	47
Stage
II	123	66	57
III-IV	227	51	39
LDH level
Normal	227	61	53
Above upper normal limit	123	56	43
Bulky disease
Absent	252	68	55
Present	98	49	41
Extranodal sites
Absent	207	62	50
Present	143	55	48
Histologic subtype
Centroblastic	182	63	52
Immunoblastic	98	60	47
Anaplastic large cell	21	57	48
Peripheral T cell	49	55	46
Performance status
0-1	212	67	56
2	138	50	40

Factor	No. of Patients	CR Rate (%)	5-Year Overall Survival (%)
Age (yr)
60-69	189	61	53
70-79	94	59	51
≥80	67	56	47
Sex
Male	174	57	48
Female	176	59	50
B symptoms
Absent	238	60	50
Present	112	57	47
Stage
II	123	66	57
III-IV	227	51	39
LDH level
Normal	227	61	53
Above upper normal limit	123	56	43
Bulky disease
Absent	252	68	55
Present	98	49	41
Extranodal sites
Absent	207	62	50
Present	143	55	48
Histologic subtype
Centroblastic	182	63	52
Immunoblastic	98	60	47
Anaplastic large cell	21	57	48
Peripheral T cell	49	55	46
Performance status
0-1	212	67	56
2	138	50	40